These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 37112726)

  • 21. Protective effects of high-potency FMDV O
    Horsington J; Perez CB; Maradei E; Novo SG; Gonzales JL; Singanallur NB; Bonastre P; Vosloo W
    Vaccine; 2017 Sep; 35(38):5179-5185. PubMed ID: 28789849
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Duration of protection and humoral immunity induced by an adenovirus-vectored subunit vaccine for foot-and-mouth disease (FMD) in Holstein steers.
    Sitt T; Kenney M; Barrera J; Pandya M; Eckstrom K; Warner M; Pacheco JM; LaRocco M; Palarea-Albaladejo J; Brake D; Rieder E; Arzt J; Barlow JW; Golde WT
    Vaccine; 2019 Sep; 37(42):6221-6231. PubMed ID: 31493951
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Safety of PRRSV-2 MLV vaccines administrated via the intramuscular or intradermal route and evaluation of PRRSV transmission upon needle-free and needle delivery.
    Madapong A; Saeng-Chuto K; Tantituvanont A; Nilubol D
    Sci Rep; 2021 Nov; 11(1):23107. PubMed ID: 34845289
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy of a high potency O1 Manisa monovalent vaccine against heterologous challenge with foot-and-mouth disease virus of O/SEA/Mya-98 lineage in sheep.
    Singanallur NB; Pacheco JM; Arzt J; Stenfeldt C; Fosgate GT; Rodriguez L; Vosloo W
    Antiviral Res; 2017 Sep; 145():114-122. PubMed ID: 28780422
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Booster administration can make a difference in the antibody response to intradermal foot-and-mouth disease vaccination in cattle.
    Çokçalışkan C; Tuncer-Göktuna P; Sareyyüpoğlu B; Türkoğlu T; Yıldız M; Deveci MNF; Aras-Uzun E; Arslan A; Kürkçü A; Uzunlu E; Asar E
    Arch Virol; 2022 Feb; 167(2):405-413. PubMed ID: 35034176
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Foot-and-Mouth Disease Virus neutralizing antibodies production induced by pcDNA3 and Sindbis virus based plasmid encoding FMDV P1-2A3C3D in swine.
    Dory D; Rémond M; Béven V; Cariolet R; Zientara S; Jestin A
    Antiviral Res; 2009 Jul; 83(1):45-52. PubMed ID: 19501256
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The immunopotentiator CVC1302 enhances immune efficacy and protective ability of foot-and-mouth disease virus vaccine in pigs.
    Chen J; Yu X; Zheng Q; Hou L; Du L; Zhang Y; Qiao X; Hou J; Huang K
    Vaccine; 2018 Dec; 36(52):7929-7935. PubMed ID: 30470640
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Robust Protection against Highly Virulent Foot-and-Mouth Disease Virus in Swine by Combination Treatment with Recombinant Adenoviruses Expressing Porcine Alpha and Gamma Interferons and Multiple Small Interfering RNAs.
    Kim SM; Park JH; Lee KN; Kim SK; You SH; Kim T; Tark D; Lee HS; Seo MG; Kim B
    J Virol; 2015 Aug; 89(16):8267-79. PubMed ID: 26041279
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A canine adenovirus type 2 vaccine vector confers protection against foot-and-mouth disease in guinea pigs.
    De Vleeschauwer AR; Zhou X; Lefebvre DJ; Garnier A; Watier F; Pignon C; Lacour SA; Zientara S; Bakkali-Kassimi L; De Clercq K; Klonjkowski B
    Vaccine; 2018 Apr; 36(16):2193-2198. PubMed ID: 29544690
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Investigation of honey bee venom effect on the immunogenicity of foot-and-mouth disease vaccine in sheep.
    Eweis ARF; Hassan KM; Shoman SAH; Taha HA; Mohamed EE
    Open Vet J; 2022; 12(6):919-928. PubMed ID: 36650860
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Thermostable negative-marker foot-and-mouth disease virus serotype O induces protective immunity in guinea pigs.
    Ranjitha HB; Dhanesh VV; Hosamani M; Sreenivasa BP; Jabeen U; Biswal JK; Saravanan P; Sanyal A; Bhanuprakash V; Basagoudanavar SH
    Appl Microbiol Biotechnol; 2023 Feb; 107(4):1285-1297. PubMed ID: 36656322
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rational design and efficacy of a multi-epitope recombinant protein vaccine against foot-and-mouth disease virus serotype A in pigs.
    Cao Y; Li D; Fu Y; Bai Q; Chen Y; Bai X; Jing Z; Sun P; Bao H; Li P; Zhang J; Ma X; Lu Z; Liu Z
    Antiviral Res; 2017 Apr; 140():133-141. PubMed ID: 28161579
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of novel inactivated vaccine for type C foot-and-mouth disease in cattle and pigs.
    You SH; Jo HE; Choi JH; Ko MK; Shin SH; Lee MJ; Kim SM; Kim B; Park JH
    Vet Microbiol; 2019 Jul; 234():44-50. PubMed ID: 31213271
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serological Conversion through a Second Exposure to Inactivated Foot-and-Mouth Disease Virus Expressing the JC Epitope on the Viral Surface.
    Hwang SY; Shin SH; Park SH; Lee MJ; Kim SM; Lee JS; Park JH
    Vaccines (Basel); 2023 Sep; 11(9):. PubMed ID: 37766163
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Scale-Up Production of Type O and A Foot-and-Mouth Disease Bivalent Vaccine and Its Protective Efficacy in Pigs.
    Park SH; Lee SY; Kim JS; Kim AY; Park SY; Lee JH; Lee M; Kim H; Lee SI; Kang NY; Park JW; Kim SM; Park JH; Ko YJ
    Vaccines (Basel); 2021 Jun; 9(6):. PubMed ID: 34199359
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Combined administration of synthetic RNA and a conventional vaccine improves immune responses and protection against foot-and-mouth disease virus in swine.
    Borrego B; Blanco E; Rodríguez Pulido M; Mateos F; Lorenzo G; Cardillo S; Smitsaart E; Sobrino F; Sáiz M
    Antiviral Res; 2017 Jun; 142():30-36. PubMed ID: 28315707
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Early protection in sheep against intratypic heterologous challenge with serotype O foot-and-mouth disease virus using high-potency, emergency vaccine.
    Horsington J; Zhang Z; Bittner H; Hole K; Singanallur NB; Alexandersen S; Vosloo W
    Vaccine; 2015 Jan; 33(3):422-9. PubMed ID: 25483241
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A Temperature-Dependent Translation Defect Caused by Internal Ribosome Entry Site Mutation Attenuates Foot-and-Mouth Disease Virus: Implications for Rational Vaccine Design.
    Yang D; Sun C; Gao R; Wang H; Liu W; Yu K; Zhou G; Zhao B; Yu L
    J Virol; 2020 Jul; 94(16):. PubMed ID: 32493820
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Assessment of the potency and effectiveness of a heptavalent oil-adjuvanted (ISA 206) foot-and-mouth disease vaccine in Egypt.
    Bazid AH; Amer HM; Nayel M; Attia M; Maklad N; Wasfy M; Abdelmegeid M; El-Sayed MM; Magouz A; Badr Y
    Arch Virol; 2023 Jan; 168(2):62. PubMed ID: 36633687
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immune Modulatory Potential of Anti-idiotype Antibodies as a Surrogate of Foot-and-Mouth Disease Virus Antigen.
    Naveed A; Rahman SU; Arshad MI; Aslam B
    mSphere; 2018 Oct; 3(5):. PubMed ID: 30333183
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.